OTS 2025 Budapest
WuXi AppTec is pleased to participate in OTS 2025 (21st Annual Meeting of the Oligonucleotide Therapeutics Society), held October 19–22, 2025 at the Budapest Congress Center, Budapest, Hungary.
OTS 2025 is a premier gathering of scientists, industry leaders, and innovators in the field of oligonucleotide and nucleic acid therapeutics. The meeting features deep dives into antisense, siRNA, aptamers, immunostimulatory oligonucleotides, delivery technologies, and translational development strategies.
At OTS 2025, sessions will span discovery of novel oligonucleotide modalities, optimization of chemistry and delivery, analytical and bioassay development, regulatory and safety challenges, and mechanisms of action. This provides an ideal environment to engage on real-world bottlenecks—such as improving oligo stability, achieving effective intracellular delivery, and bridging preclinical assets to clinical candidates.
At WuXi AppTec, our integrated platform supports the full lifecycle of oligonucleotide programs. From custom chemistry, analytical method development, in vitro / in vivo profiling, formulation and delivery optimization, to GMP manufacturing of clinical-grade oligonucleotides, we aim to help you de-risk and accelerate your development path.
We invite you to meet with our team to explore how our oligonucleotide capabilities can complement your projects. To schedule a dedicated meeting during OTS 2025, please fill out the form on the right.
Resource Links
Research Chemistry Services
Resource Type: Brochure
WuXi AppTec Biology Services
Resource Type: Brochure
Oligonucleotide Services
Resource Type: Brochure
